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Abstract: Hepatitis C virus (HCV) genome multiplication requires the concerted action of 
the viral RNA, host factors and viral proteins. Recent studies have provided information 
about the requirement of specific viral RNA motifs that play an active role in the viral 
life cycle. RNA regulatory motifs controlling translation and replication of the viral RNA 
are mostly found at the 5' and 3' untranslated regions (UTRs). In particular, viral protein 
synthesis is under the control of the internal ribosome entry site (IRES) element, a complex 
RNA structure located at the 5'UTR that recruits the ribosomal subunits to the initiator 
codon. Accordingly, interfering with this RNA structural motif causes the abrogation of the 
viral cycle. In addition, RNA translation initiation is modulated by cellular factors, 
including miRNAs and RNA-binding proteins. Interestingly, a RNA structural motif 
located at the 3'end controls viral replication and establishes long-range RNA-RNA 
interactions with the 5'UTR, generating functional bridges between both ends on the viral 
genome. In this article, we review recent advances on virus-host interaction and translation 
control modulating viral gene expression in infected cells. 
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1. Introduction: The HCV Viral Genome 
Hepatitis C virus (HCV) is a member of the Hepacivirus genus, within the Flaviviridae family, 
responsible for non-A non-B hepatitis, affecting about 3% of the human population worldwide. HCV 
causes persistent infection leading to severe liver damage, including cirrhosis, hepatic steatosis and 
hepatocellular carcinoma. The virus is predominantly transmitted through the parenteral route during 
contaminated blood transfusions as well as needle sharing among injecting drug users. Currently, there 
is no vaccine against HCV. Medical treatment of infected patients with pegylated interferon (IFN)-α 
and ribavirin is effective only in 40% of the infected population. More recently, a combination of this 
therapy with viral protease-inhibitors has improved virus clearance, reaching 60% of the HCV 
patients [1]. However, efficacy of the treatment depends on the particular HCV genotype [2]. It is well 
established that the HCV viral genome displays a large genetic variability [3–6]. This property is 
shared with other RNA viruses [7]. There are six different HCV genotypes, each one including 
multiple variants arising during viral replication as a consequence of the lack of proofreading activity 
of the viral RNA-dependent RNA polymerase. Furthermore, the high mutation rate of this virus 
facilitates the emergence of resistant viral genomes during therapeutic treatment [8]. 
The viral genome consists of a single-stranded RNA of positive polarity, about 9.5 kb in length 
(Figure 1). Untranslated regions (UTR) located at the 5' and 3'end of the genome flank a single open 
reading frame (ORF), which encodes a polyprotein of about 3,000 amino acids [9]. The polyprotein is 
processed by viral and cellular proteases rendering the mature viral proteins. Structural proteins (core, 
E1, E2) are encoded in the most N-terminal region of the ORF, while the non-structural (NS) proteins 
(p7, NS2, NS3, NS4B, NS5A and NS5B) reside in the most C-terminal region. Core is a 
multifunctional protein that modulates viral and cellular gene expression, in addition to forming part of 
the viral nucleocapsid. E1 and E2 are the envelope glycoproteins that control receptor-mediated cell 
entry. P7 is an essential protein that appears to form an ion channel in lipid bilayers. NS2 is a cysteine 
protease while NS3 is a serine protease within its N-terminal and possess helicase and NTPase activity. 
NS3 together with NS4A are responsible for the processing of the viral polyprotein between NS3/4A, 
NS4A/B, NS4B/5A and NS5A/B. NS4B induces membranes in infected cells associated to the viral 
replication process; NS5A cooperates in viral replication with NS5B, the viral RNA-dependent 
polymerase. Additionally, NS5A has been implicated in the modulation of the IFN response. 
In common with other single-stranded positive-sense RNA viruses, the 5' and 3'UTRs of HCV 
contain essential structural motifs that exert critical regulatory functions, controlling viral RNA 
translation and replication [10,11]. The viral RNA is uncapped; instead, the 5'UTR contains an RNA 
regulatory region termed internal the ribosome entry site (IRES) element (Figure 1), which drives 
translation initiation using a cap-independent mechanism. Additionally, the 3'end of the viral genome 
does not possess a poly(A) tail; rather, a poly(U/C) tract at the 3'end precedes a three stem-loops 
region termed 3'X [12]. Both 5' and 3'end regulatory elements perform crucial roles during viral 
multiplication that differ strongly from the mechanisms used by the host cell. Furthermore, viral 
protein synthesis is the first intracellular step of the virus multiplication cycle; thereby, these RNA 
motifs constitute candidate targets for antiviral molecules. 
Most eukaryotic mRNAs initiate translation using a cap-dependent mechanism, by which the 
m7GpppN (cap) at the 5'end of the mRNA is recognized by the eukaryotic initiation factor (eIF)4F 
Viruses 2012, 4  
 
 
2235 
complex (consisting of the cap-binding factor eIF4E, the RNA helicase eIF4A, and the scaffold protein 
eIF4G that in turn, interacts with eIF4E, eIF4A, eIF3 and the poly(A)-binding protein (PABP)). This 
complex, bound to the 40S small ribosomal subunit, scans the 5'UTR of mRNA in 5' to 3' direction 
until an initiation codon is encountered in the appropriate context [13]. In contrast to this general 
mechanism used by host cell mRNAs, initiation of protein synthesis in various viral mRNAs 
(exemplified by picornaviruses) occurs internally, driven by IRES elements [14], using a mechanism 
that evades the inhibition of translation initiation usually occurring in infected cells. Early after the 
discovery of IRES elements in the genomic RNA of picornaviruses, an IRES element was reported to 
drive translation initiation of the HCV genomic RNA [15]. 
Figure 1. Diagram of the hepatitis C virus genome. Processing of the single polyprotein 
renders the mature viral proteins Core, E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A and 
NS5B. The stem-loop I at the 5' untranslated regions (UTR) and the CRE element located 
within the coding region of NS5B are required for viral replication. The structural elements 
of the 3'UTR region referred to in the text (the variable region VR, the polyU/C tract pU/C, 
and the 3'X region with stem-loops SLI, SLI, and SLIII) are schematically represented. 
 
2. Structure and Function of the Hepatitis C IRES Element 
Alignment of RNA sequences obtained from clinical isolates corresponding to the HCV IRES 
region indicated that, though variable, this is the most conserved region of the genome [16]. This 
feature that is commonly found in RNA regulatory motifs is indicative of the superposition of RNA 
structural constrains in this part of the genome. Accordingly, HCV IRES activity is strongly dependent 
on its RNA structure organization [17,18]. Evidence for tight links between RNA structure and 
biological function is provided by the conservation of structural motifs within IRES elements of highly 
variable RNA viruses [14,19]. Although some positive-strand RNA viruses (including Picornaviruses, 
Hepaciviruses and Pestiviruses) share the overall organization of their genomic RNA, IRES elements 
present in these viral genomes are organized in high-order structures that not only differ profoundly 
among them, but also with other viral IRES elements [20–24]. In all cases, RNA structure of viral 
IRES elements including HCV and the related GB virus B (GBV-B) is organized in modules that are 
phylogenetically conserved [25–30]. More specifically, in many RNA viruses it has been 
experimentally demonstrated that mutations leading to the disruption of specific RNA structure motifs 
impaired IRES activity while the corresponding compensatory mutations restored IRES function [31].  
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The HCV IRES spans a region of approximately 340 nt that encompasses most of the 5'UTR of the 
viral mRNA and the first 30–40 nt of the core-coding region [31]. Variants of the 5'UTR isolated from 
HCV infected patients show distinct effects on IRES activity depending on their location within the 
RNA structure and the type of cell line used to determine IRES activity [26,27]. Specifically, the HCV 
IRES is arranged in conserved structural domains II, III and IV, from 5' to 3' direction, each of them 
organized in short subdomains (Figure 2). Besides these conserved stem-loops, a pseudoknot (pK) 
located upstream of the AUG start codon is a typical feature of the HCV IRES. This overall domain 
organization is conserved among Hepaciviruses, Pestiviruses [24,28] and some members of the 
Picornaviridae family that possess HCV-like IRES elements [22].  
Figure 2. Schematic representation of the Hepatitis C virus (HCV) internal ribosome entry 
site (IRES) element and surrounding stem-loops. The IRES domains II, III, and IV, with 
stem-loops IIab and IIIabcdef, the pseudoknot (Pk), as well as the location of the initiator 
AUG codon in the loop of domain IV are depicted. The interaction sites of eIF3 and the 
40S ribosomal subunit within the IRES element are highlighted. Domain I (involved in 
RNA replication) as well as the binding sites of miR-122 are depicted by a hairpin and red 
bars, respectively. A red asterisk in stem-loop VI depicts a sequence potentially annealing 
with the target region of miR-122, proposed to lock the IRES element in a closed 
conformation. 
 
 
Given the critical role of the IRES element during HCV multiplication cycle, the RNA structural 
organization as well as the function of the distinct HCV IRES domains has been analyzed extensively. 
Domain II consists of two subdomains, IIa and IIb [32]. The RNA structure of subdomain IIa adopts an 
L-shape conformation essential for IRES activity [33]. This subdomain appears to direct the apical 
loop IIb towards the E site of the ribosome (tRNA-exit site). Accordingly, it has been recently found 
that domain IIb affects the RNA conformation in the decoding groove of the 40S ribosomal 
subunit [34].  
Domain III is the larger domain of HCV IRES (Figure 2); it consists of stem-loops IIIabcdef, 
organized in three and four-way junctions [35,36], which appear to have a division of functions. The 
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entire domain III is required for positioning the mRNA start codon correctly on the 40S ribosomal 
subunit during translation initiation, but the IIIdef region is sufficient to form a high-affinity 
interaction binary complex with the 40S ribosomal subunit in the absence of eIFs. The apical region of 
this domain (IIIabc) contains the eIF3-binding site [37]. The basal region is organized in three 
stem-loops (IIIdef) that can fold as a pseudoknot structure [38]. A particular feature of domain IIId 
conserved among all genotypes of HCV is the presence of an internal loop E motif [36], an RNA motif 
also present in domain II and other structured RNAs such as the 5S RNA. The three-dimensional 
structure of domain III solved recently reveals a complex pseudoknot that establishes the alignment of 
two helical elements on either side of the four-helix junction [39], constraining the orientation of the 
open reading frame for positioning on the 40S ribosomal subunit.  
From the mechanistic point of view, binding of the HCV IRES to the 40S ribosomal subunit is the 
first step of translation initiation on the viral RNA [40–42]. As mentioned above, interaction with the 
40S subunit requires hairpins IIIcdef of the IRES [37], while domain II helps to accommodate 
the mRNA in the tRNA-exit site of the ribosome and mediates eIF2 release during 80S ribosome 
assembly [43,44]. Following assembly of the binary 40S-IRES complex, eIF3 and the ternary complex 
eIF2-GTP-tRNAi are recruited to form the 48S initiation complex [17]. In full agreement with these 
data, direct interaction of the polypeptides conforming eIF3 with the HCV IRES has been identified by 
different approaches, including UV-crosslink, mass spectrometry of IRES-bound protein complexes 
and cryo-electron microscopy [45–49]; furthermore, the ribosomal proteins that participate in 
IRES-40S interaction have been identified by cross-linking and mass spectrometry [41,50].  
This specific mode of internal initiation of translation is not unique to HCV; HCV-like IRES 
elements with similar eIF requirements have been found in the genome of some picornaviruses [51,52] 
as well as in the pestiviruses [18]. Specifically, the interaction sites with the 40S ribosomal subunit and 
eIF3 are conserved between HCV and HCV-like IRES elements. Furthermore, covariation between a 
purine-purine mismatch near the pseudoknot and the loop sequence of domain IIIe maintains a tertiary 
interaction that stabilizes the pseudoknot structure and correlates with translational efficiency in the 
HCV-like porcine teschovirus-1 talfan and HCV IRES elements [52]. 
Besides this structural and mechanistic conservation between pestiviruses and the HCV-like IRES 
of picornaviruses, there are features conserved with more distant IRES elements. Indeed,  
cryo-electron microscopy studies of the IRES elements of HCV and the intergenic region (IGR) of 
dicistroviruses (a pseudoknotted IRES element that does not need eIFs to recruit the 40S ribosomal 
subunit) showed that these RNAs are accommodated in the interface of the ribosomal subunits in a 
similar manner [44,53]. Furthermore, and despite the different structural organization of the IGR IRES 
of dicistroviruses and the HCV IRES elements, both interact with the ribosomal protein RpS25 [54] 
and induce similar conformational changes in the 40S ribosomal subunit. This characteristic opens the 
possibility that IRES elements could possess a structural motif mediating their direct interaction with 
the 40S subunit.  
The IRES property of interacting with the ribosome is an attractive possibility to explain internal 
initiation of translation, which is supported by the finding that IRES activity is differentially sensitive 
to changes in ribosome composition [55]. Another feature shared among the IRES elements of 
dicistroviruses, picornaviruses and pestiviruses is their recognition as substrate of RNase P, the tRNA 
precursor-processing ribozyme [56–58], a result that led to propose the existence of tRNA-like motifs 
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within the HCV IRES element [59]. tRNA-like motifs, often present in RNA viruses, could be 
inherited from RNA replication signals accommodated to assist in the translation process. Indeed, plant 
RNA viruses make use of tRNA-like structures to control cap-independent translation initiation and 
viral RNA replication [60,61] assisted by RNA-RNA interactions between the 3' and the 5'UTR of the 
viral genome. 
3. Host Factors Controlling HCV Protein Synthesis 
Besides ribosomal proteins and eIFs, RNA-binding proteins that play important roles in gene 
expression help to promote IRES-dependent translation acting as IRES-transacting factors 
(ITAFs) [62]. Indeed, a number of riboproteomic approaches have facilitated the identification of 
proteins interacting with different IRES elements including HCV [48,49,63]. One of the proteins 
specifically identified in HCV IRES-40S ribosomal complexes is the receptor for activated protein 
kinase C (RACK1) [49], a protein that recruits protein kinase C to the 40S subunit. Despite the large 
differences in RNA structure organization, various ITAFs are shared between the IRES elements of 
HCV and picornaviruses, providing evidences of common characteristics between distant IRES 
elements that could be related to similar mechanisms of action. Amongst others, examples of common 
factors between HCV and picornavirus IRES elements are PTB, PCBP2, nucleolin, Gemin5, unr, 
hnRNPA1/A2, La autoantigen (La) and NS1-associated protein (NSAP1) [64–68]. In most cases 
ITAFs stimulate translation initiation (PTB), although there are examples of translation repressors 
(Gemin5) [67]. Whether these factors exert their function directly or through the action of other 
partners in the complex remains elusive. However, the fact that most of these proteins also contribute 
to other processes of the cellular gene expression program establishes a network of interactions linking 
translation control with other RNA-based events such as splicing, transport, or stability of cellular 
mRNAs. Most of these steps are altered in infected cells due to changes in localization, 
post-translational modification or proteolysis of key components of the cellular machinery responsible 
for these processes [69]. 
In addition to eIFs, ribosomal subunits and RNA-binding proteins, HCV subverts the liver-specific 
microRNA miR-122 to upregulate viral RNA abundance [70]. miR-122 interacts with the 5' end of the 
HCV RNA genome (Figure 2) using two binding sites located 8 or 9-nucleotide apart, depending on 
the HCV isolate. Both binding sites are occupied by miR-122 and function cooperatively to regulate 
viral gene expression [71], forming a tandem oriented oligomeric RNA complexes assembled at  
the 5' terminus of the HCV RNA. In this complex, each miR-122 molecule utilize similar internal 
nucleotides to interact with the viral genome, creating a bulge and tail in the miRNAs [72], likely 
protecting the 5' terminal viral sequences from nucleolytic degradation or from inducing innate 
immune responses to the RNA terminus. 
miR-122 stimulates HCV IRES-mediated translation [73]. In agreement with this, other authors 
proposed that the HCV IRES resides within a locked conformation in the naked RNA owing to the 
annealing of its flanking sequences (Figure 2), and that miR-122 unlocks this high-order RNA 
structure exposing the IRES element to an open conformation [74]. However, comparison of the 
replication capacity of a double miR-122 binding-site mutant and a defective IRES mutant suggests 
that the decrease in translation efficiency associated with loss of miR-122 binding does not account for 
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the defect in virus production by the double mutant [75]. This result suggests that miR-122 could be 
acting at an additional step in the virus life cycle. In this regard, it has been recently reported that 
miR-122 positively regulates the viral life cycle in culture cells by stimulating HCV translation 
mediated by Argonaute proteins through a process that requires uncapped RNA, the HCV IRES and 
the 3' region of miR-122 [76]. This mechanism of translation activation by an Ago-containing miRISC 
complex differs from the one described earlier [74], proposed to occur in vitro using naked RNA. 
4. Interference with HCV Translation Inhibits Viral Multiplication 
The large difference in the mechanism used by the HCV RNA to initiate translation makes this step 
of the viral multiplication cycle an ideal target in the development of antivirals. With this aim, many 
investigators have explored the inactivation of the virus by the development of therapeutic approaches 
involving direct targeting of the IRES region as well as the interference of specific host factors 
required for viral RNA translation. Attempts to block IRES activity directly with antisense 
oligonucleotides, peptide nucleic acids (PNAs), locked nucleic acid (LNAs), DNA and RNA aptamers, 
RNAi and ribozymes have been widely explored [77–80]. Of interest, an LNA antisense oligonucleotide 
with potent antiviral activity targeted the region containing both miR-122 binding sites [81], 
supporting the critical role of this part of the genome in controlling the viral multiplication cycle. 
Screening of small molecule inhibitor libraries has yielded limited success to control HCV 
multiplication [82]. However, a benzimidazole molecule that binds to HCV IRES subdomain IIa [83] 
reduces viral protein expression and inhibits viral RNA replication [84]. Structural studies aimed at 
understanding the mechanism of action of this small molecule indicated a conformational change of 
domain II induced by the binding of the drug that impaired IRES activity [85,86]. The recent 
resolution of the three-dimensional structure of the IRES subdomain IIa in complex with this molecule 
revealed a binding mode that resembles the substrate binding sites in riboswitches [87], explaining its 
interference with the translation process. 
Although many attempts to inhibit different steps of the HCV multiplication cycle have been done 
in vitro, using cell-free systems or tissue culture cells, the lack of a convenient laboratory animal 
model has hampered the development of effective therapies. Interestingly, expression of two human 
genes, CD81 and occludin, has been shown to be sufficient to allow HCV infection of fully 
immunocompetent inbred mice [88]. This animal model opens new avenues for studying viral 
pathogenesis in addition to provide a platform for testing HCV therapeutic drugs.  
5. Implications of Viral RNA 5'-3' End Interactions on IRES Activity and the Infection Cycle  
The untranslated regions of the genome of positive-strand RNA viruses contain phylogenetically 
conserved functional elements that play essential roles during the viral cycle. These specialized 
structural motifs are recognized by viral and host RNA-binding proteins that control translation, 
replication and interaction of viral replication complexes with host cell structures. These processes 
have been studied in great detail in HCV that harbors RNA structural elements on each end of the viral 
genome (Figure 1). Interestingly, functional links between these distant regulatory regions has been 
shown to affect HCV gene expression. Thus, besides the regulatory function of the IRES region in 
translation initiation of the viral RNA, a translation enhancer function of the HCV 3' UTR variable 
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region, the poly(U/C) tract, and the 3' terminal stem-loop 1 of the conserved 3'X region (Figure 1) was 
reported [89]. Along this idea, long-range RNA-RNA interactions between the 5' and the 3'end of the 
viral genome were observed [90]. This interaction specifically involved the apical loop of domain IIId 
of the IRES (Figure 2) and the internal loop of 5BSL3.2 within the cis-acting replication element 
(CRE) (Figure 1), a structural region that is essential for the initiation of viral replication [91]. The 
5BSL3.2 motif forms part of a cruciform structure at the 3' end of the NS5B coding sequence that 
contributes to the three-dimensional folding of the 3' end of the genome by generating a kissing loop 
with the SL2 of the 3'X region [92].  
A functional role of the IRES-5BSL3.2 long-range RNA interaction in translation control has been 
recently documented [93]. Mutations in 5BSL3.2 motif lead to an increase in IRES activity, supporting 
the existence of a high order structure in the HCV genome that involves domain IIId in the IRES and 
stem-loop 5BSL3.2. Other authors, however, have not detected this long-distant interaction [94]. The 
tertiary structure of the 3'UTR of HCV is not known yet. It appears that different long-range 
interactions may exist in this region, with significant differences between distinct HCV genotypes, as 
revealed by RNA structure mapping of this region by selective 2'-hydroxyl acylation and analyzed by 
primer extension (SHAPE) methodology [94]. This study has proposed a regulatory function of the 
5BSL3.2 RNA motif in the switch from translation to replication of the viral RNA, two mutually 
incompatible events that use the same template. 
Genome circularization promoted by direct RNA-RNA contacts involving inverted complementary 
sequences has been shown to be essential for viral replication in the case of flaviviruses [95]. In other 
RNA viruses, RNA-RNA interaction between the 3' and the 5' UTR sequences of the genome control 
cap-independent translation initiation [96]. Similarly, a functional link between the IRES and the 3' 
end of the viral RNA was earlier suggested by the specific stimulation of the aphthovirus IRES activity 
by the viral 3' UTR [97]. This link could take place through direct RNA-RNA contacts, through 
protein bridges mediating RNA circularization, or both [98,99]. Notwithstanding, host RNA-binding 
proteins NF90/NFAR mediate 5'-3' contacts in the genome of HCV and pestiviruses [100,101].  
In the search of factors that could generate functional bridges between the ends of the HCV viral 
genome, it was found that the insulin-like growth factor II mRNA-binding protein 1 (IGF2BP1) is 
present in complexes assembled with RNAs that contained both the HCV IRES and the 3'UTR. This 
protein coimmunoprecipitates with eIF3 and the 40S ribosomal subunit [63] suggesting that it 
enhances HCV IRES activity by recruiting the ribosomal subunits to a pseudo-circularized RNA. 
These results provide a mechanistic basis for translation stimulation and replication of the viral RNA 
resembling the synergistic stimulation of cap-dependent translation. Furthermore, expression of DDX6 
(Rck/p54, a member of the DEAD-box RNA helicase family) is required for optimal HCV replication. 
Overexpression of DDX6 enhanced replication, whereas a helicase-deficient mutant had a  
dominant-negative effect reducing HCV yields. Formation of a complex containing DDX6, HCV core 
protein, and both viral and cellular RNAs, was dependent upon the C-terminal domain of DDX6 [102]. 
In this respect, requirement of HCV RNA translation and replication on Rck/p54, LSm1, and PatL1, 
which regulate the mRNA decay pathway, was linked to the 5' and 3' UTRs of the viral genome [103].  
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6. Modulation of Viral and Cellular Gene Expression in Infected Cells: Implications for Viral 
Pathogenesis  
HCV, as all RNA viruses, depends on the host cell machinery to synthesize the proteins necessary 
for viral replication. Consequently, RNA viruses have developed specialized strategies to subvert the 
cellular machinery in their own benefit, including cellular translation factors and signaling pathways 
that control host protein synthesis [69]. In turn, the cell has evolved responses to recognize and fight 
the incoming infectious agent. Cells infected by RNA viruses accumulate double-stranded RNA 
(dsRNA), leading to the activation of the cellular RNA-dependent protein kinase (PKR), a protein that 
has a key role in the innate immunity response to viral infection [104]. PKR is responsible for 
phosphorylation of eIF2α, causing a reduction of eIF2.GTP.Met-tRNAi ternary complex, and thus 
inhibiting mRNA translation [13]. To counteract this response, RNA viruses have evolved multiple 
strategies. In addition of using a cap-independent IRES-dependent translation initiation mechanism, 
HCV mRNA evades the inhibitory effects of eIF2α phosphorylation by using an alternative initiator 
tRNA-binding protein, eIF2A. HCV RNA recruits eIF2A to the HCV IRES via direct interaction with 
the IIId domain and subsequent loading of Met-tRNAi to the P site of the 40S ribosomal subunit [105]. 
Furthermore, HCV RNA translation is independent of eIF2 under high concentrations of MgCl2 in cell 
free systems [106]; whether this also occurs in infected cells is unknown.  
An alternative way used by RNA viruses to control the translation repression effect induced by the 
host stress response to infection is to take advantage of the oscillation in this response to prevent 
continuing translation repression [107]. Virus infection-induced translation inhibition is linked to 
assembly of stress granules (SGs). HCV infection induces a dynamic assembly of SGs, concomitant 
with phases of active and stalled translation, delayed cell division, and prolonged cell survival. eIF2α 
phosphorylation by PKR mediates SG formation and translation arrest. This event is antagonized by 
the upregulation of GADD34, the regulatory subunit of protein phosphatase 1 dephosphorylating 
eIF2α. At least in part, these oscillations are reminiscent of the fluctuations in cell viability and 
virulence observed during coevolution of cells and viruses in other persistent infections, such as 
foot-and-mouth disease virus [108]. The latter establishes persistent infections in carrier animals and in 
tissue culture cells and uses IRES-dependent translation to drive viral protein synthesis while 
inactivating host cell gene expression by proteolysis of translation factors and RNA-binding  
proteins [99,108–110]. However, HCV infection does not trigger the proteolysis of eIFs and  
RNA-binding proteins needed for cellular mRNA translation [111]. These observations suggest that 
viral infection can establish persistent infection by using different manners to coordinate host cell 
proliferation and viral gene expression. 
HCV-induced persistent infection reflects the evasion of host immunity and interference with IFN 
innate immune defenses. Cellular antiviral immunity, among others, is based on the host recognition of 
virus dsRNA intermediates, which are sensed by Toll-like receptor 3 (TLR3) and the RNA helicase 
RIG-I (retinoic acid inducible gene I). Detection of dsRNA results in the activation of the transcription 
factors interferon regulatory factor 3 (IRF3) and NF-kappaB. CARD-adaptor proteins interact with 
RIG-I and recruits IKK kinases, leading to the activation of NF-kappaB and IRF3. However,  
the HCV NS3-4A viral serine protease cleaves cardif (a CARD-adaptor protein also known as the  
mitochondria-antiviral signaling protein MAVS) [112] as well as the Toll-IL-1 receptor  
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domain-containing adaptor inducing IFN-beta (TRIF) [113] interfering with host innate immune 
defenses by blocking IFN-β production. Consistent with this, PKR inhibition restored IFN induction in 
infected cells until a decrease in IFN expression could be attributed to NS3/4A-mediated MAVS 
cleavage [114].  
The response of the cell to HCV infection affects various pathways that may differ between 
individual patients, determining the outcome of the infection. In fact, both cytopathic effects and 
immune-mediated processes play an important role in liver injury. At least in part this has been 
illustrated by cell lines that have different permissiveness to infection and show a differential 
expression of genes linked to the innate immune response, secreted signal peptides and host factors 
that have a role in virus entry and replication [115]. On the other hand, the induction of cell-death 
related genes and the activation of caspase-3 in HCV-infected cells is coincident with viral replication, 
suggesting a link between viral load and apoptosis [116]. Furthermore, transgenic mice expressing 
HCV proteins recapitulate the hallmarks of HCV infection [117]. Consistent with this, interactions of 
HCV-encoded proteins with cell cycle regulators and tumor suppressor proteins suggest that HCV can 
alter cellular proliferation control [118]. Further studies aimed at understanding the interplay between 
virus replication and cell response to infection are needed to shed light on this important persistent 
human pathogen. 
7. Perspectives 
Understanding the biological role of RNA regulatory elements present in the HCV genome has 
received great attention in the last years. In particular, the concerted action of these signals alongside 
host and viral factors is essential to control the viral multiplication cycle and at the same time to 
maintain the permissiveness of the cell to a sustained persistent infection. Mechanistic aspects that 
explain at the molecular level how HCV RNA structures and viral proteins participate in the infection 
process still need to be investigated in detail. In particular, efforts towards identifying functionally 
relevant interactors of the viral RNA regulatory elements, as well as viral proteins, will provide 
information about their mechanism of action. An important question is how these functional structures 
control the switch from translation to replication and later to encapsidation of the viral genome. In 
recent years, it has become evident that dynamic conformational changes controlled by RNA-RNA, 
RNA-protein and miRNA-RNA interactions modulate viral replication in the viral genome. This view 
of the viral genome as a flexible molecule will help in understanding the function of RNA structures 
formed at different stages of the viral life cycle. Deciphering how these high order structures are 
assembled in the context of the whole viral genome and how these macromolecular complexes govern 
the viral multiplication cycle is ahead of us. 
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